Gradual tapering of benzodiazepine receptor agonists, antidepressants, antipsychotics, and gabapentinoids after medium- or long-term use (>2 weeks) is recommended to discontinue hypnotic medications.
The paper recommends that hypnotic medications such as benzodiazepine receptor agonists, antidepressants, antipsychotics, and gabapentinoids should be tapered gradually after use exceeding 2 weeks, with a weekly dose reduction of 10-25%. Abrupt discontinuation is only recommended for short-term use (1-2 weeks) or for drugs without withdrawal symptoms like daridorexant, melatonin, antihistamines, and phytotherapeutics. A longer taper is advised for high-dose (≥2/3 of maximum) or long-term (≥1 year) use.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Gradual tapering of benzodiazepine receptor agonists, antidepressants, antipsychotics, and gabapentinoids after medium- or long-term use (>2 weeks) is recommended to discontinue hypnotic medications. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Gradual tapering of benzodiazepine receptor agonists, antidepressants, antipsychotics, and gabapentinoids after medium- or long-term use (>2 weeks) is recommended to discontinue hypnotic medications.
This conclusion is most relevant to: Patients with insomnia who are taking hypnotic medications, including those with dependence..
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Recommendations on Switching or Deprescribing Hypnotic Medications for Insomnia. (Deutsches Arzteblatt international, 2026) —
How It Works
The proposed biological pathway:
- ▸Assess duration and dose of hypnotic use.
- ▸If use >2 weeks and drug class is benzodiazepine receptor agonist, antidepressant, antipsychotic, or gabapentinoid, initiate gradual tapering.
- ▸Reduce dose by 10-25% weekly, adjusting based on patient response and withdrawal symptoms.
- ▸Result: Reduced withdrawal symptoms and successful discontinuation.
Who Might Benefit
Evidence fit by population:
- ▸Patients with insomnia who are taking hypnotic medications, including those with dependence.
Recommended Dose
Weekly dose reduction of 10-25% for gradual tapering; longer taper for high-dose or long-term use.
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Narrative review, not a systematic review or meta-analysis, so evidence synthesis may be less rigorous.
- ▸Recommendations are based on consensus and may not be universally applicable across all patient subgroups or healthcare settings.
- ▸The abstract does not provide specific patient-level data or effect sizes for the tapering recommendation.
Frequently Asked Questions
Which hypnotic drugs can be stopped abruptly?▼
Drugs that do not produce withdrawal symptoms, such as daridorexant (orexin receptor antagonist), melatonin, antihistamines, and phytotherapeutic drugs, can be stopped abruptly after short-term use (1-2 weeks).
How should benzodiazepine receptor agonists be tapered?▼
Benzodiazepine receptor agonists should be tapered gradually with a weekly dose reduction of 10-25% after medium- or long-term use (>2 weeks).
What is the recommended taper duration for high-dose or long-term users?▼
A longer taper is advisable for patients using high doses (≥2/3 of maximum dose) or for long-term use (≥1 year).
Can withdrawal symptoms be managed during tapering?▼
Withdrawal symptoms from benzodiazepine receptor agonists can be alleviated with overlapping administration of daridorexant or eszopiclone, and behavioral therapy is recommended as an accompanying nonpharmacological treatment.
References
- 1.Hajak G, Fietze I, Schöbel C, Saletu M, Högl B, Winter Y. “Recommendations on Switching or Deprescribing Hypnotic Medications for Insomnia..” Deutsches Arzteblatt international, 2026. PMID: 42535778 DOI: 10.3238/arztebl.m2026.0141